Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Normal" thrombin generation.

S Butenas1, C van't Veer, K G Mann

  • 1Department of Biochemistry, University of Vermont, Burlington, VT, USA.

Blood
|September 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel microfluidic device for factor VIII quantification by chemiluminescence in hemophilia A patients.

Biosensors & bioelectronics·2025
Same author

Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Effects of an acidic environment on coagulation dynamics.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Activation, activity and inactivation of factor VIII in factor VIII products.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Altering plasma coagulation factor levels significantly impacts thrombin generation, with prothrombin and antithrombin III (AT-III) being dominant factors. These findings suggest potential risk factors for thrombosis and the need for predictive testing algorithms.

Area of Science:

  • Biochemistry
  • Hematology
  • Thrombosis Research

Background:

  • Plasma coagulation factors are crucial for hemostasis.
  • Understanding factor level variations' impact on thrombin generation is key to thrombosis research.
  • Existing predictive models for thrombosis may not fully capture individual factor dynamics.

Purpose of the Study:

  • To investigate the in vitro influence of altered plasma coagulation factor levels on thrombin generation.
  • To identify key factors that predominantly affect thrombin production.
  • To explore potential risk factors for thrombosis based on factor level variations.

Main Methods:

  • Synthetic plasma systems were created using purified, natural, and recombinant proteins and phospholipids.
  • Reactions were initiated with recombinant tissue factor (TF)-factor VIIa complex.

Related Experiment Videos

  • Levels of 11 coagulation factors and inhibitors (AT-III, TFPI) were varied between 50% and 150%.

    • Main Results:

    • Extreme inverse alterations in procoagulants and anticoagulants resulted in a 28-fold difference in thrombin generated.
    • Prothrombin and AT-III were identified as the dominant factors influencing thrombin generation.
    • Increased prothrombin or decreased AT-III significantly elevated thrombin generation, suggesting potential thrombosis risk.

    Conclusions:

    • Individual variations in prothrombin and AT-III levels significantly impact thrombin generation.
    • Elevated prothrombin and reduced AT-III may be risk factors for thrombosis.
    • Predictive thrombosis tests may require algorithms that integrate multiple coagulation factor levels.